Smoking Increases Side Effect, Recurrence Risk in Prostate Cancer
the ONA take:
The fact that smoking contributes to a poor prognosis in many diseases and conditions is well-known. A recent study from Memorial Sloan Kettering Cancer Center in New York City confirmed the effects on smoking on patients with prostate cancer.
Those who smoke have increased risks of experiencing treatment-related side effects and cancer recurrences, or even dying from the disease. These researchers studied 2,358 patients who underwent external beam radiotherapy for prostate cancer between 1988 and 2005, of which 2,156 had a history of smoking.
Risk of cancer relapse was 40% higher and risk of metastasis and cancer-related death was more than 2-times higher in patients who were current smokers compared with patients who were never smokers.
Current and former smokers also had a higher likelihood of experiencing side effects, such as urinary toxicity, related to radiotherapy. "Less optimal tumor control outcomes among smokers could possibly be explained by the influence of less oxygen concentration within the treated tumors among smokers, which is known to lead to less sensitivity of the cells being killed off by radiation treatments," the researchers noted.
Recent study confirmed the effects on smoking on patients with prostate cancer.
Sign Up for Free e-newsletters
- Scalp Cooling With Dignicap May Reduce Alopecia During Chemotherapy for Breast Cancer
- Evolution of HER2-Positive Breast Cancer: Yesterday, Today, and Tomorrow
- Dedicated End-of-Life Education Program Improves Nurses' Care, Patient and Family Satisfaction
- Reflexology, Aromatherapy May Reduce Pain, Anxiety of Brachytherapy for Cervical Cancer
- Oncology Extended Care Clinic Reduced Urgent Cancer-Related ED Visits
- Hair Dyes and Cancer Risk (Fact Sheet)
- Taste Changes After Hematopoietic Stem Cell Transplant Affect QOL in Blood Cancers
- Hope, Optimism Reduce Psychological Distress in Advanced Cancer
- Mitomycin Extravasation Protocol
- Accurate Understanding of Capacity May Improve Workflow, Efficiency in Infusion Suite
- Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
- Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
- Online Program Aims to Assist With Clinical Trial Enrollment for Hematologic Cancers
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Skipping the SICU Post Head and Neck Cancer Surgery May Improve Outcomes
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|